Steve Schonfeld’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Steve Schonfeld's ARQT Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 20,303 shares worth $537K. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ARQT as recently as Q3 2025.
Steve Schonfeld first reported a position in ARQT in Q1 2022 and has held it in 9 quarters since. The position peaked at $7.29M in Q2 2025. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Steve Schonfeld held 20,303 shares of Arcutis Biotherapeutics worth $537K as of Q3 2026.
- Arcutis Biotherapeutics was a new Steve Schonfeld position in Q3 2026.
- Arcutis Biotherapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1936 holding.
- Steve Schonfeld first reported a position in Arcutis Biotherapeutics in Q1 2022 and has held it in 9 quarters since.
- Steve Schonfeld's Arcutis Biotherapeutics position peaked at $7.29M in Q2 2025.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.